Jordi Llaneras

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

José Luís Calleja, Javier Crespo, Diego Rincón et al. · Journal of Hepatology · 2017 · 188 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

Jordi Llaneras, Mar Riveiro‐Barciela, Sabela Lens et al. · Journal of Hepatology · 2019 · 100 citations · Full text

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +10

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules

Zoe Mariñó, Anna Darnell, Sabela Lens et al. · Journal of Hepatology · 2019 · 84 citations · Full text

Medicine, Oncology, Carcinogenesis +16

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

Qian Chen, Celia Perales, María Eugenia Soria et al. · Antiviral Research · 2019 · 47 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination

Jordi Llaneras, J. Cobo, Ariadna Rando‐Segura et al. · JHEP Reports · 2023 · 30 citations · Full text

Medicine, Emergency Medicine, Infectious Diseases +14